TNYA earnings date and last-quarter result: last quarter beat, P/E -1.68. Updated 2026-07-23.
Tenaya Therapeutics (TNYA) Research Hub
Tenaya Therapeutics (TNYA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.4086 USD (+5.04%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.68, market cap 0.13B. This hub links to the full technical, earnings and options research available for TNYA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.4086 USD (+5.04%) |
| 52-week range | 0.3601 USD – 0.947 USD |
| Trend regime | Range |
| 14-day RSI | 31.5 (Bearish) |
| Trailing P/E | -1.68 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for TNYA
Covered Call on TNYA: how it works, illustrative setup around the real 0.4086 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TNYA: how it works, illustrative setup around the real 0.4086 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TNYA: how it works, illustrative setup around the real 0.4086 USD price, max profit/loss, breakeven and when to use it. Educational.
TNYA technical analysis: range, last 0.4086 USD, RSI 31.5, 52w range 0.3601 USD–0.947 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TNYA in?
Tenaya Therapeutics (TNYA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TNYA in an uptrend or downtrend?
As of 2026-10-26, TNYA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TNYA's trailing P/E ratio?
TNYA's trailing P/E is -1.68, with a market cap of 0.13B. See the earnings research page for full valuation detail.